R1 RCM key facts
as of Oct 2026- Provider of revenue cycle management services intended to serve hospitals, health systems, and physician groups.
- R1 RCM is valued at approximately $8.9B as of Oct 2026 (last reported valuation).
- It has raised $3.2M.
- Notable investors include Khosla Ventures, TowerBrook Capital Partners, Clayton, Dubilier & Rice.
- Status: Privately Held (backing).
R1 RCM's last reported valuation, Nov 2024. Nothing priced has surfaced since.
- ·Watch R1 RCM: the Monday email on marks, rounds and moves
R1 RCM funding rounds
No funding rounds for R1 RCM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs R1 RCM
4R1 RCM valuation
R1 RCM's last reported valuation was $8.9 billion in Nov 2024. No priced round, secondary trade or fund mark has surfaced since.
R1 RCM investors
4 investors are on record for R1 RCM, including Khosla Ventures, TowerBrook Capital Partners, Clayton and Dubilier & Rice.
About R1 RCM
Provider of revenue cycle management services intended to serve hospitals, health systems, and physician groups. The company offers end-to-end revenue cycle services, including personnel, technology, and process workflow, enabling clients to improve operating margins and cash flow while enhancing patient, physician, and staff satisfaction.
- Sector
- Healthcare
- HQ
- Murray, UT, United States
- Founded
- 2003
- Employees
- 34,000
- Website
- r1rcm.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.